Abcam, ab267234, Human MEX3B knockout HEK-293T cell line

Size: 2 x 1000000Cells / vial / 1000000Cells / vial
MEX3B KO cell line available to order. KO validated by. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 14 bp deletion in exon 2 and 1 bp deletion in exon 2 and 1 bp insertion in exon 2. To order both knockout and wild-type control cells: select 2 x 1000000Cells/vial. To order only knockout cells: select 1000000Cells/vial.
Key facts
Cell type:HEK-293T,
Species or organism:Human,
Tissue:Kidney,
Form:LiquidSee storage information,
Knockout validation:Sanger Sequencing,
Mutation description:Knockout achieved by using CRISPR/Cas9, 14 bp deletion in exon 2 and 1 bp deletion in exon 2 and 1 bp insertion in exon 2

Product details:
We will provide viable cells that proliferate on revival.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our
limited use license
patent pages

Properties and Storage Information:
Gene name-MEX3B, Gene editing type-Knockout, Gene editing method-CRISPR technology, Knockout validation-Sanger Sequencing, Shipped at conditions-Dry Ice, Appropriate short-term storage conditions--196°C, Appropriate long-term storage conditions--196°C

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
MEX3B also known as RNA-binding E3 ubiquitin protein ligase MEX-3B is a protein with a molecular mass of approximately 66 kDa. It functions mechanically as an RNA-binding protein equipped with two K homology (KH) domains and an ubiquitin E3 ligase domain. MEX3B shows expression in various tissues including brain and testis. The protein participates in the post-transcriptional regulation of mRNA influencing stability and localization of its target mRNAs.
Biological function summary
MEX3B influences cellular processes by regulating gene expression at the post-transcriptional level. It is a component of the ribonucleoprotein complexes involved in mRNA turnover and translation regulation. MEX3B assists in fine-tuning the expression of genes critical for cell differentiation and growth. The protein mediates degradation of selected mRNAs by marking them for decay through the ubiquitin-proteasome pathway.
Pathways
MEX3B engages in pathways such as Wnt/β-catenin signaling and mTOR signaling. Through these pathways the protein impacts cell proliferation and survival. In the Wnt/β-catenin pathway MEX3B influences AXIN1 degradation affecting β-catenin levels. In mTOR signaling MEX3B collaborates with proteins like PI3K modulating cellular responses to growth factors and nutrients.
Altered expression of MEX3B correlates with cancer and neurological disorders. In cancer MEX3B may potentially influence tumor progression by affecting oncogene and tumor suppressor mRNA stability interacting with proteins such as β-catenin. In neurological disorders its role in mRNA regulation suggests a connection with neurodegenerative conditions often through interactions with mRNA-regulating proteins like HuR.